Abstract
AbstractThe integration of thrombolysis into paramedicine practice has brought about a significant paradigm shift in the treatment and prognosis of patients with STEMI (ST-Elevation Myocardial Infarction). This innovative approach has led to a notable increase in patient survival rates, demonstrating its effectiveness. A crucial aspect of this transformative change is the noteworthy reduction in “door-to-needle” time, a critical benchmark in STEMI management. As we delve deeper into examining this shift, it becomes increasingly evident that its impact extends beyond the immediate and convenient on-scene medical intervention. Instead, it fundamentally alters the trajectory of patient outcomes, highlighting the evolving role of paramedicine within the realm of medical care.
Publisher
Springer Science and Business Media LLC